Wound care management involves dressings, equipment, and other aids, such as bandages, gels, and ostomy drainage bags, designed to prevent and treat wounds, as well as to promote or accelerate wound healing. Surgical Adhesion Barriers are medical implants that are used to reduce abnormal internal scarring, or adhesions, following surgery by separating the internal tissues and organs while they heal. GlobalData uses proprietary data and analytics to provide a comprehensive report on the surgical adhesion barriers devices market, including market shares of different players within Japan. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the surgical adhesion barriers market in Japan was Baxter International followed by W. L. Gore & Associates, Ethicon and Integra LifeSciences.
Adhesions are bands of scar-such as tissue that form abnormal fibrous connections joining tissue surfaces in abnormal locations. In general, any type of transperitoneal operation can lead to the formation of adhesions ranging from minimal scarring of serosal surface to firm agglutination of nearly all structures. However, post-surgical adhesion has a considerable epidemiological and clinical impact mostly due to tissue damage caused by surgical traumas. Gel Surgical Adhesion Barriers are gel-based products directly applied or sprayed at the site (open or laparoscopic) of surgery to prevent adhesions between the tissue planes. Membrane Surgical Adhesion Barriers are available in the form of fabrics, films and membranes.
The value of the surgical adhesion barriers devices market within Japan was expected to be over $40m in 2023.
For the latest complete market share analysis of surgical adhesion barriers device market in Japan, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
The medical devices pipeline data used in this article were obtained from the Medical Pipeline Products Database of GlobalData’s Medical Intelligence Center. Pipeline Products database is a comprehensive source of information on medical devices, it covers 39K products which are in development stage and intended for diagnosis, treatment, and management of diseases/conditions/symptoms directly or indirectly. The pipeline products included in the database are sourced from reliable and authenticated sources, such as company websites, SEC filings, conference presentations, analyst presentations, news releases, clinical trial registries, and grants. The information is collected by following systematic research techniques and proprietary methodology.
